Elanco Animal Health Incorporated
$22.34
▼
-1.19%
2026-04-22 10:12:13
www.elanco.com
NYQ: ELAN
Explore Elanco Animal Health Incorporated stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$11.2 B
Current Price
$22.34
52W High / Low
$27.72 / $8.02
Stock P/E
—
Book Value
$13.17
Dividend Yield
—
ROCE
2.14%
ROE
-3.67%
Face Value
—
EPS
$-0.47
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
9,400
Beta
1.88
Debt / Equity
67.89
Current Ratio
2.17
Quick Ratio
1.08
Forward P/E
19.78
Price / Sales
2.45
Enterprise Value
$15.4 B
EV / EBITDA
16.96
EV / Revenue
3.27
Rating
Buy
Target Price
$28.77
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | SCYNEXIS, Inc. | $1.07 | — | $47.85 M | — | -30.16% | -16.48% | $1.31 / $0.56 | $1.13 |
| 2. | ANI Pharmaceuticals, Inc. | $81.73 | 23.13 | $1.81 B | 0.06% | 6.99% | 16.16% | $99.5 / $56.71 | $25.8 |
| 3. | China Pharma Holdings, Inc. | $0.67 | — | $26.84 M | — | -46.43% | -20.91% | $2.6 / $0.5 | $1.47 |
| 4. | PRF Technologies Ltd. | $2.64 | — | $2.31 M | — | -53.59% | -90.37% | $17.95 / $1.8 | $10.29 |
| 5. | Gelteq Limited | $0.7 | — | $7.5 M | — | -31.25% | -42.99% | $4.11 / $0.64 | $1.09 |
| 6. | InMed Pharmaceuticals Inc. | $0.72 | — | $2.4 M | — | -57.63% | -97.2% | $7.98 / $0.57 | $3.42 |
| 7. | Aurora Cannabis Inc. | $3.72 | — | $285.82 M | — | 1.34% | -15.51% | $9.33 / $4.29 | $6.8 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 1.14 B | 1.14 B | 1.24 B | 1.19 B | 1.02 B | — |
| Operating Profit | 19 M | 27 M | 85 M | 121 M | 8 M | — |
| Net Profit | -276 M | -34 M | 11 M | 67 M | -8 M | — |
| EPS in Rs | -0.55 | -0.07 | 0.02 | 0.13 | -0.02 | 0.73 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 4.71 B | 4.44 B | 4.42 B | 4.41 B |
| Operating Profit | 252 M | 251 M | 326 M | 384 M |
| Net Profit | -232 M | 338 M | -1.23 B | -78 M |
| EPS in Rs | -0.46 | 0.68 | -2.47 | -0.16 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 13.36 B | 12.61 B | 14.36 B | 15.49 B |
| Total Liabilities | 6.81 B | 6.52 B | 8.14 B | 8.2 B |
| Equity | 6.55 B | 6.1 B | 6.22 B | 7.29 B |
| Current Assets | 3.46 B | 3.21 B | 3.41 B | 3.28 B |
| Current Liabilities | 1.6 B | 1.31 B | 1.24 B | 1.7 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 560 M | 541 M | 271 M | 452 M |
| Investing CF | -279 M | 1.16 B | -169 M | -179 M |
| Financing CF | -275 M | -1.49 B | -83 M | -549 M |
| Free CF | 284 M | 394 M | 131 M | 268 M |
| Capex | -276 M | -147 M | -140 M | -184 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 0.5% | 0.14% | — | — |
| Earnings Growth % | 127.46% | -1478.21% | — | — |
| Profit Margin % | 7.61% | -27.87% | -1.77% | — |
| Operating Margin % | 5.65% | 7.38% | 8.71% | — |
| Gross Margin % | 54.88% | 56.28% | 56.63% | — |
| EBITDA Margin % | 31.2% | -5.07% | 19.29% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.